{
  "id": "6222257e3a8413c653000077",
  "type": "factoid",
  "question": "What are TAMs in cancer therapy?",
  "ideal_answer": "TAMs are Tumor Associated Macrophages and are important in Cancer therapy.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34515617",
    "http://www.ncbi.nlm.nih.gov/pubmed/29730267",
    "http://www.ncbi.nlm.nih.gov/pubmed/34060821",
    "http://www.ncbi.nlm.nih.gov/pubmed/34006822",
    "http://www.ncbi.nlm.nih.gov/pubmed/31704343",
    "http://www.ncbi.nlm.nih.gov/pubmed/28341752",
    "http://www.ncbi.nlm.nih.gov/pubmed/29436395",
    "http://www.ncbi.nlm.nih.gov/pubmed/32445205",
    "http://www.ncbi.nlm.nih.gov/pubmed/25620672",
    "http://www.ncbi.nlm.nih.gov/pubmed/34469109",
    "http://www.ncbi.nlm.nih.gov/pubmed/34276698",
    "http://www.ncbi.nlm.nih.gov/pubmed/33568427",
    "http://www.ncbi.nlm.nih.gov/pubmed/29691294",
    "http://www.ncbi.nlm.nih.gov/pubmed/34695762",
    "http://www.ncbi.nlm.nih.gov/pubmed/32708142",
    "http://www.ncbi.nlm.nih.gov/pubmed/33881837",
    "http://www.ncbi.nlm.nih.gov/pubmed/33050070"
  ],
  "snippets": [
    {
      "text": " tumor-associated macrophages (TAMs) ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34695762",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tumour-associated macrophages (TAMs)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33568427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " tumor-associated macrophages (TAMs)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34469109",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tumor-associated macrophages (TAMs)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34515617",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, endocrine therapy resistance mechanisms mediated through interactions between breast cancer cells and tumor-associated macrophages (TAMs) are still unclear.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34006822",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ntional cancer therapy also strengthens cancer-related inflammation by inducing massive tumor cell death that activate surrounding immune-infiltrating cells such as tumor-associated macrophages (TAMs). Mac",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34276698",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although M2-like tumor-associated macrophages (TAMs) have been considered as a vital therapeutic target in cancer therapy due to their role in promoting tumor progression and metastasis, very few compounds have been identified to inhibit M2-like polarization of TAMs. H",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29730267",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Eliciting effective antitumor immune responses in patients who fail checkpoint inhibitor therapy is a critical challenge in cancer immunotherapy, and in such patients, tumor-associated myeloid cells and macrophages (TAMs) are promising therapeutic targets. We",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29436395",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As CSCs depend on their specific niche, including tumor-associated macrophages (TAM), elucidating the network between CSCs and TAMs may help to effectively inhibit the progression and ADT resistance of prostate cancer.Experimental Design: The underlying intracellular mechanism that sustains the stem-like characteristics of CSCs in prostate cancer was assessed via RNA sequencing, co-immunoprecipitation, chromatin immunoprecipitation, and other assays.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29691294",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor-associated macrophages (TAMs) is a promising therapeutic target for cancer immunotherapy, while TAMs targeting therapy using nano-sized drug delivery system (NDDS) is a great challenge.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31704343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor-associated macrophages (TAMs) play a crucial part in cancer evolution.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34060821",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor-associated macrophages (TAMs) of M2 phenotype have mediated the immunosuppression in a tumor microenvironment, facilitating the escape of tumor cells from immunosurveillance.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33881837",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this review, we outline the importance of tumor-associated macrophages (TAM), a major component of the TME, in the response of tumors to cancer therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28341752",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In particular, tumor-associated macrophages (TAMs) are the most abundant leucocyte subset in many cancers and play a major role in the creation of a protective niche for tumor cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33050070",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These cells, known as tumor-associated macrophages (TAMs), play complex but pivotal roles in the outcome of photodynamic therapy (PDT) of malignant lesions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25620672",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor-associated macrophages (TAMs) represent the most abundant innate immune cells in tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32708142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the TME.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32445205",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Tumor Associated Macrophages"
}